BDNF, NT-3 and Trk Receptor Agonist Monoclonal Antibodies Promote Neuron Survival, Neurite Extension, and Synapse Restoration in Rat Cochlea Ex Vivo Models Relevant for Hidden Hearing Loss

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Nov 1

PMID 31671109

Citations 26

Authors

Stephanie Szobota

Pranav D Mathur

Sairey Siegel

KristenAnn Black

H Uri Saragovi

Alan C Foster

Affiliations

Soon will be listed here.

Abstract

Neurotrophins and their mimetics are potential treatments for hearing disorders because of their trophic effects on spiral ganglion neurons (SGNs) whose connections to hair cells may be compromised in many forms of hearing loss. Studies in noise or ototoxin-exposed animals have shown that local delivery of NT-3 or BDNF has beneficial effects on SGNs and hearing. We evaluated several TrkB or TrkC monoclonal antibody agonists and small molecules, along with BDNF and NT-3, in rat cochlea ex vivo models. The TrkB agonists BDNF and a monoclonal antibody, M3, had the greatest effects on SGN survival, neurite outgrowth and branching. In organotypic cochlear explants, BDNF and M3 enhanced synapse formation between SGNs and inner hair cells and restored these connections after excitotoxin-induced synaptopathy. Loss of these synapses has recently been implicated in hidden hearing loss, a condition characterized by difficulty hearing speech in the presence of background noise. The unique profile of M3 revealed here warrants further investigation, and the broad activity profile of BDNF observed underpins its continued development as a hearing loss therapeutic.

Citing Articles

Selective inhibitors of the TrkC.T1 receptor reduce retinal inflammation and delay neuronal death in a model of retinitis pigmentosa.

Brahimi F, Nassour H, Galan A, Guruswamy R, Ortiz C, Nejatie A PNAS Nexus. 2025; 4(2):pgaf020.

PMID: 39911316 PMC: 11795507. DOI: 10.1093/pnasnexus/pgaf020.

Expression of Neurotrophins and Its Receptors During Fetal Development in the Human Cochlea.

Steinacher C, Nishio S, Usami S, Dudas J, Rieder D, Rask-Andersen H Int J Mol Sci. 2024; 25(23).

PMID: 39684722 PMC: 11641258. DOI: 10.3390/ijms252313007.

Decreasing the physical gap in the neural-electrode interface and related concepts to improve cochlear implant performance.

Vecchi J, Claussen A, Hansen M Front Neurosci. 2024; 18:1425226.

PMID: 39114486 PMC: 11303154. DOI: 10.3389/fnins.2024.1425226.

Exploring Neuronal Differentiation Profiles in SH-SY5Y Cells through Magnetic Levitation Analysis.

Bilginer Kartal R, Yildiz A ACS Omega. 2024; 9(13):14955-14962.

PMID: 38585102 PMC: 10993277. DOI: 10.1021/acsomega.3c08962.

Oxidative Stress Plays an Important Role in Glutamatergic Excitotoxicity-Induced Cochlear Synaptopathy: Implication for Therapeutic Molecules Screening.

Saidia A, Francois F, Casas F, Mechaly I, Venteo S, Veechi J Antioxidants (Basel). 2024; 13(2).

PMID: 38397748 PMC: 10886292. DOI: 10.3390/antiox13020149.

References

Kujawa S, Liberman M . Synaptopathy in the noise-exposed and aging cochlea: Primary neural degeneration in acquired sensorineural hearing loss. Hear Res. 2015; 330(Pt B):191-9. PMC: 4567542. DOI: 10.1016/j.heares.2015.02.009. View

Pujol R, Puel J, Gervais dAldin C, Eybalin M . Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol. 1993; 113(3):330-4. DOI: 10.3109/00016489309135819. View

Yu Q, Chang Q, Liu X, Gong S, Ye K, Lin X . 7,8,3'-Trihydroxyflavone, a potent small molecule TrkB receptor agonist, protects spiral ganglion neurons from degeneration both in vitro and in vivo. Biochem Biophys Res Commun. 2012; 422(3):387-92. PMC: 3388121. DOI: 10.1016/j.bbrc.2012.04.154. View

Wise A, Richardson R, Hardman J, Clark G, OLeary S . Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J Comp Neurol. 2005; 487(2):147-65. DOI: 10.1002/cne.20563. View

Seyyedi M, Viana L, Nadol Jr J . Within-subject comparison of word recognition and spiral ganglion cell count in bilateral cochlear implant recipients. Otol Neurotol. 2014; 35(8):1446-50. PMC: 4139064. DOI: 10.1097/MAO.0000000000000443. View

Sahenk Z, Nagaraja H, McCracken B, King W, Freimer M, Cedarbaum J . NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology. 2005; 65(5):681-9. DOI: 10.1212/01.wnl.0000171978.70849.c5. View

Cazorla M, Arrang J, Premont J . Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor. Br J Pharmacol. 2010; 162(4):947-60. PMC: 3042204. DOI: 10.1111/j.1476-5381.2010.01094.x. View

Wang Q, Green S . Functional role of neurotrophin-3 in synapse regeneration by spiral ganglion neurons on inner hair cells after excitotoxic trauma in vitro. J Neurosci. 2011; 31(21):7938-49. PMC: 3132175. DOI: 10.1523/JNEUROSCI.1434-10.2011. View

Boltaev U, Meyer Y, Tolibzoda F, Jacques T, Gassaway M, Xu Q . Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists. Sci Signal. 2017; 10(493). DOI: 10.1126/scisignal.aal1670. View

10.

Jin Y, Kondo K, Ushio M, Kaga K, Ryan A, Yamasoba T . Developmental changes in the responsiveness of rat spiral ganglion neurons to neurotrophic factors in dissociated culture: differential responses for survival, neuritogenesis and neuronal morphology. Cell Tissue Res. 2012; 351(1):15-27. PMC: 3577061. DOI: 10.1007/s00441-012-1526-1. View

11.

Jang S, Liu X, Yepes M, Shepherd K, Miller G, Liu Y . A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci U S A. 2010; 107(6):2687-92. PMC: 2823863. DOI: 10.1073/pnas.0913572107. View

12.

Kalra S, Genge A, Arnold D . A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003; 4(1):22-6. DOI: 10.1080/14660820310006689. View

13.

Sahenk Z, Galloway G, Edwards C, Malik V, Kaspar B, Eagle A . TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice. Exp Neurol. 2010; 224(2):495-506. DOI: 10.1016/j.expneurol.2010.05.013. View

14.

FRANK L, Ventimiglia R, Anderson K, Lindsay R, Rudge J . BDNF down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons. Eur J Neurosci. 1996; 8(6):1220-30. DOI: 10.1111/j.1460-9568.1996.tb01290.x. View

15.

Sommerfeld M, Schweigreiter R, Barde Y, Hoppe E . Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB. J Biol Chem. 2000; 275(12):8982-90. DOI: 10.1074/jbc.275.12.8982. View

16.

Sly D, Campbell L, Uschakov A, Saief S, Lam M, OLeary S . Applying Neurotrophins to the Round Window Rescues Auditory Function and Reduces Inner Hair Cell Synaptopathy After Noise-induced Hearing Loss. Otol Neurotol. 2016; 37(9):1223-30. DOI: 10.1097/MAO.0000000000001191. View

17.

Suzuki J, Corfas G, Liberman M . Round-window delivery of neurotrophin 3 regenerates cochlear synapses after acoustic overexposure. Sci Rep. 2016; 6:24907. PMC: 4842978. DOI: 10.1038/srep24907. View

18.

Kobayashi K, Suzuki H . Synapse-selective rapid potentiation of hippocampal synaptic transmission by 7,8-dihydroxyflavone. Neuropsychopharmacol Rep. 2018; 38(4):197-203. PMC: 7292275. DOI: 10.1002/npr2.12033. View

19.

. A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology. 1999; 52(7):1427-33. DOI: 10.1212/wnl.52.7.1427. View

20.

Kujawa S, Liberman M . Adding insult to injury: cochlear nerve degeneration after "temporary" noise-induced hearing loss. J Neurosci. 2009; 29(45):14077-85. PMC: 2812055. DOI: 10.1523/JNEUROSCI.2845-09.2009. View